smartbax
biotech company developing antibiotics against multi-drug resistant bacteria
smartbax has raised €1.2M across 1 funding round from 2 investors, most recently a Seed round in May 2023. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.
Munich, Germanywww.smartbax.de ↗
Total raised
€1.2M
€1,200,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearsmartbax — funding by year — interactive chart.
Data table
| smartbax — funding by year | |
|---|---|
| 2023 | €1.2M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-23 | Seed | €1.2M | Boehringer Ingelheim Venture Fund (BIVF),High-Tech Gründerfonds (HTGF) | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData